Non-alcoholic fatty liver disease (NAFLD), now renamed as Metabolic Associated Steatotic Liver Disease (MASLD), has traditionally been seen as a condition affecting adults. However, alarming data now ...
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...
INR:0976. sistem pragmatic play Will the 4+7 ratio in domestic orthopedics be reversed? Will the high-value consumables industry usher in changes? Scientist ...